Optical coherence tomography as a novel diagnostic tool for distal type chronic thromboembolic pulmonary hypertension

Circulation Journal

Volumn 74, Issue 8, 2010, Pages 1742-1744

  Tatebe, Shunsuke ^a   Fukumoto, Yoshihiro ^a   Sugimura, Koichiro ^a   Nakano, Makoto ^a   Miyamichi, Saori ^a   Satoh, Kimio ^a   Oikawa, Minako ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; SEX RATIO;

ADULT; AGED; BLOOD VESSELS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; THROMBOEMBOLISM; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 77955084164     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0160     Document Type: Article

References (9)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classifcation of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43-S54.
2. Tanimoto T, Imanishi T, Tanaka A, Yamano T, Kitabata H, Takarada S, et al. Various types of plaque disruption in culprit coronary artery visualized by optical coherence tomography in a patient with unstable angina. Circ J 2009; 73: 187-189.
3. Sawada T, Shite J, Negi N, Shinke T, Tanino Y, Ogasawara D, et al. Factors that infuence measurements and accurate evaluation of stent apposition by optical coherence tomography: Assessment using a phantom model. Circ J 2009; 73: 1841-1847.
4. Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, et al. Long-term follow-up of neointimal coverage of siroli-mus-eluting stents: Evaluation with optical coherence tomography. Circ J 2009; 73: 2300-2307.
5. Palevsky HI, Schloo BL, Pietra GG, Weber KT, Janicki JS, Rubin E, et al. Primary pulmonary hypertension: Vascular structure, mor-phometry, and responsiveness to vasodilator agents. Circulation 1989; 80: 1207-1221.
6. Fukumoto Y, Tawara S, Shimokawa H. Recent progress in the treatment of pulmonary arterial hypertension: Expectation for Rho-kinase inhibitors. Tohoku J Exp Med 2007; 211: 309-320.
7. Doe Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, et al. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 2009; 73: 1731-1739.
8. Lang IM, Klepetko W. Chronic thromboembolic pulmonary hypertension: An updated review. Curr Opin Cardiol 2008; 23: 555-559.
9. Yoshimi S, Tanabe N, Masuda M, Sakao S, Uruma T, Shimizu H, et al. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension. Circ J 2008; 72: 958-965.